ERBB2 and breast cancer: To assess the subtypes of HR+/HER2-0 and HR+/HER2-low breast cancer, 50 genes across diverse breast cancer cell lines were examined using PAM50 typing (GSE212143) derived from transcriptome data in the GEO database30.